Company intelligence / Profile preview
VASTHERA
Seoul, South Koreavasthera.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Preclinical
01
Overview
VasThera is a Korea-based pharmaceutical company developing first-in-class synthetic therapeutics targeting redox and autophagy signaling pathways implicated in chronic inflammatory and vascular diseases. Its lead candidate, VTB‑10 for pulmonary arterial hypertension, is expected to enter Phase 1 trials in 2025. The company leverages its proprietary Redoxizyme™ platform to generate small molecule Prx-mimetics that restore cellular redox balance. Additional pipeline programs target cancer, neurodegeneration, and eye disease at the preclinical stage.[1][2][3]
- Therapeutic areas
- OphthalmologyOncologyCardiovascularNeurology
- Modalities
- Small moleculesEnzyme mimetics (nanozymes)Biological products[8]
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Currently undergoing due diligence for a partnership/licensing-out agreement with strong prospects by end of year; no specific partners named yet.[3]Private equity owner includes Shinhan Venture Investment.[7]
Beyond the preview
Go deeper on VASTHERA.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on VASTHERA.